How did Zentek's revenue and expenses trend in Q3 2025 compared to previous quarters?

Zentek's revenue and expenses for Q3 2025 are not currently available. However, the company's recent announcements provide insights into its business activities and partnerships, which may indicate trends in revenue and expenses. 1. **No Available Data**: There are no available records of Zentek's revenue or expenses for Q3 2025. 2. **Recent Announcements**: Zentek has announced a purchase order from Dexterra Group Inc. for ZenGUARD™ Enhanced Air Filters. This purchase order could potentially indicate increased revenue related to the sale of these filters. However, without specific financial information, it is difficult to ascertain the exact impact on revenue. 3. **Avian Flu Countermeasure**: Zentek has also announced the commencement of the testing phase for its avian influenza countermeasure after successfully completing the first phase of a contract with the Government of Canada. This project is funded by Canada's Innovative Solutions Canada Testing Stream and is valued at approximately CAD 1.1 million. The testing phase is a critical milestone, and if successful, it could lead to additional revenue opportunities. However, the financial implications of this project in Q3 2025 are not clear. 4. **Strategic Partnerships**: Zentek has partnered with Levidian to combine their expertise in carbon capture, graphene production, and materials development to accelerate the rollout of ZenGuard Enhanced Air Filters and other graphene-enhanced products. These partnerships could potentially lead to new revenue streams and opportunities for growth, but again, specific financial data for Q3 2025 is not available. In conclusion, while Zentek's recent announcements suggest potential for revenue growth, particularly from the sale of ZenGUARD™ Enhanced Air Filters and the development of avian influenza countermeasures, there is no available data to provide a detailed picture of the company's financial performance in Q3 2025.